<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7291320\results\search\drug\results.xml">
  <result pre="small single-arm study from France has tested the effect of" exact="hydroxychloroquine" post="(an analogue of chloroquine) and azithromycin on the respiratory"/>
  <result pre="tested the effect of hydroxychloroquine (an analogue of chloroquine) and" exact="azithromycin" post="on the respiratory viral loads in patients with COVID-19"/>
  <result pre="viral loads in patients with COVID-19 [105]. Patients treated with" exact="hydroxychloroquine" post="showed a significant reduction in viral carriage by day"/>
  <result pre="favipiravir) have been applied, without clinical efficacy data available. Lastly," exact="methylprednisolone" post="is another drug under investigation (NCT04323592) that is currently"/>
  <result pre="which results in decreased serum concentrations of active metabolites of" exact="clopidogrel" post="and prasugrel and increased serum concentration of ticagrelor. Cardiac"/>
  <result pre="Careful QT monitoring is recommended especially when a combination of" exact="hydroxychloroquine" post="and azithromycin is used [109]. Lastly, the use of"/>
  <result pre="monitoring is recommended especially when a combination of hydroxychloroquine and" exact="azithromycin" post="is used [109]. Lastly, the use of corticosteroid is"/>
  <result pre="Adults Hospitalized with Severe Covid-19N. Engl. J. Med.20203821787179910.1056/NEJMoa200128232187464 104.WangM.CaoR.ZhangL.YangX.LiuJ.XuM.ShiZ.HuZ.ZhongW.XiaoG.Remdesivir and" exact="chloroquine" post="effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in"/>
  <result pre="emerged novel coronavirus (2019-nCoV) in vitroCell Res.20203026927110.1038/s41422-020-0282-032020029 105.GautretP.LagierJ.C.ParolaP.HoangV.T.MeddebL.MailheM.DoudierB.CourjonJ.GiordanengoV.VieiraV.E.et al.Hydroxychloroquine and" exact="azithromycin" post="as a treatment of COVID-19: Results of an open-label"/>
 </snippets>
</snippetsTree>
